Clinical trial NCT00721305 - References

HIV Seropositivity — Lovastatin: Immunomodulatory Value Evaluation

Citation(s)

•   Aberg JA, Zackin RA, Brobst SW, Evans SR, Alston BL, Henry WK, Glesby MJ, Torriani FJ, Yang Y, Owens SI, Fichtenbaum CJ; ACTG 5087 Study Team
  A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Res Hum Retroviruses. 2005 Sep;21(9):757-67.
•   Albi E, Viola Magni MP
  The role of intranuclear lipids. Biol Cell. 2004 Oct;96(8):657-67. Review.
•   Alfsen A, Iniguez P, Bouguyon E, Bomsel M
  Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol. 2001 May 15;166(10):6257-65.
•   Benesic A, Zilly M, Kluge F, Weissbrich B, Winzer R, Klinker H, Langmann P
  Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir. Infection. 2004 Aug;32(4):229-33.
•   Blanco-Colio LM, Tuñón J, Martín-Ventura JL, Egido J
  Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 2003 Jan;63(1):12-23. Review.
•   Bonnet F, Balestre E, Thiébaut R, Mercié P, Dupon M, Morlat P, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
  Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001. HIV Med. 2004 May;5(3):133-9.
•   Butini L, De Fougerolles AR, Vaccarezza M, Graziosi C, Cohen DI, Montroni M, Springer TA, Pantaleo G, Fauci AS
  Intercellular adhesion molecules (ICAM)-1 ICAM-2 and ICAM-3 function as counter-receptors for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation. Eur J Immunol. 1994 Sep;24(9):2191-5.
•   Calza L, Manfredi R, Chiodo F
  Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART. AIDS. 2003 Apr 11;17(6):851-9.
•   Campbell SM, Crowe SM, Mak J
  Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS. 2002 Nov 22;16(17):2253-61.
•   Cohen DE, Walker BD
  Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection. Clin Infect Dis. 2001 Jun 15;32(12):1756-68. Epub 2001 May 16. Review.
•   Del Real G, Jiménez-Baranda S, Lacalle RA, Mira E, Lucas P, Gómez-Moutón C, Carrera AC, Martínez-A C, Mañes S
  Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. J Exp Med. 2002 Aug 5;196(3):293-301.
•   del Real G, Jiménez-Baranda S, Mira E, Lacalle RA, Lucas P, Gómez-Moutón C, Alegret M, Peña JM, Rodríguez-Zapata M, Alvarez-Mon M, Martínez-A C, Mañes S
  Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med. 2004 Aug 16;200(4):541-7.
•   Fehr T, Kahlert C, Fierz W, Joller-Jemelka HI, Riesen WF, Rickli H, Wüthrich RP, Ammann P
  Statin-induced immunomodulatory effects on human T cells in vivo. Atherosclerosis. 2004 Jul;175(1):83-90.
•   Fernández C, Lobo Md Mdel V, Gómez-Coronado D, Lasunción MA
  Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation. Exp Cell Res. 2004 Oct 15;300(1):109-20.
•   Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF
  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997 Nov 14;278(5341):1295-300.
•   Fortin JF, Cantin R, Lamontagne G, Tremblay M
  Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol. 1997 May;71(5):3588-96.
•   Fujiwara M, Tsunoda R, Shigeta S, Yokota T, Baba M
  Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interaction. J Virol. 1999 May;73(5):3603-7.
•   Garcia PJ
  Pleiotropic effects of statins: moving beyond cholesterol control. Curr Atheroscler Rep. 2005 Feb;7(1):34-9. Review.
•   Giguère JF, Tremblay MJ
  Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J Virol. 2004 Nov;78(21):12062-5.
•   Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R
  Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1993 Aug;6(8):904-12.
•   Graaf MR, Richel DJ, van Noorden CJ, Guchelaar HJ
  Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat Rev. 2004 Nov;30(7):609-41. Review.
•   Gummuluru S, Rogel M, Stamatatos L, Emerman M
  Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J Virol. 2003 Dec;77(23):12865-74.
•   Guyader M, Kiyokawa E, Abrami L, Turelli P, Trono D
  Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol. 2002 Oct;76(20):10356-64.
•   Hakamada-Taguchi R, Uehara Y, Kuribayashi K, Numabe A, Saito K, Negoro H, Fujita T, Toyo-oka T, Kato T
  Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res. 2003 Nov 14;93(10):948-56. Epub 2003 Oct 16.
•   Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, Hamann D, Prins M, Miedema F
  Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003 Sep 5;17(13):1881-8.
•   Hildreth JE, Orentas RJ
  Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science. 1989 Jun 2;244(4908):1075-8.
•   Hioe CE, Chien PC Jr, Lu C, Springer TA, Wang XH, Bandres J, Tuen M
  LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission. J Virol. 2001 Jan;75(2):1077-82.
•   Hulgan T, Sterling TR, Daugherty J, Arbogast PG, Raffanti S, Ray W
  Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):277-82.
•   Illingworth DR, Tobert JA
  HMG-CoA reductase inhibitors. Adv Protein Chem. 2001;56:77-114. Review.
•   Instituto Nacional de Salud
  Programa Nacional de Prevención y control ITS/SIDA. Colombia 1983-2002. Bogotá: Instituto Nacional de Salud, Ministerio de Salud de la República de Colombia; 2003
•   Issekutz TB
  Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1. J Immunol. 1992 Nov 15;149(10):3394-402.
•   Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, Cottens S, Weitz-Schmidt G, Hommel U
  Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol. 1999 Sep 10;292(1):1-9.
•   Kwak B, Mulhaupt F, Veillard N, Pelli G, Mach F
  The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Swiss Med Wkly. 2001 Jan 27;131(3-4):41-6.
•   Lee YM, Liu B, Yu XF
  Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes. J Virol. 1999 Jul;73(7):5654-62.
•   Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H, Madhok R, Campbell C, Gracie JA, Liew FY, McInnes IB
  A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol. 2003 Feb 1;170(3):1524-30.
•   Liang KY, Zeger SL
  Regression analysis for correlated data. Annu Rev Public Health. 1993;14:43-68. Review.
•   Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE
  Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1009-19.
•   Liao Z, Graham DR, Hildreth JE
  Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res Hum Retroviruses. 2003 Aug;19(8):675-87.
•   Liao Z, Roos JW, Hildreth JE
  Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4. AIDS Res Hum Retroviruses. 2000 Mar 1;16(4):355-66.
•   Lindwasser OW, Resh MD
  Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies. J Virol. 2004 Jun;78(11):6013-23.
•   Mañes S, del Real G, Lacalle RA, Lucas P, Gómez-Moutón C, Sánchez-Palomino S, Delgado R, Alcamí J, Mira E, Martínez-A C
  Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 2000 Aug;1(2):190-6.
•   Manfredi R, Calza L, Chiodo F
  Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART. AIDS. 2006 Feb 14;20(3):455-7.
•   Mazière JC, Landureau JC, Giral P, Auclair M, Fall L, Lachgar A, Achour A, Zagury D
  Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium. Biomed Pharmacother. 1994;48(2):63-7.
•   McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY
  A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol. 2004 Mar 1;172(5):2903-8.
•   Moncunill G, Negredo E, Bosch L, Vilarrasa J, Witvrouw M, Llano A, Clotet B, Esté JA
  Evaluation of the anti-HIV activity of statins. AIDS. 2005 Oct 14;19(15):1697-700.
•   Moore JP, Trkola A, Dragic T
  Co-receptors for HIV-1 entry. Curr Opin Immunol. 1997 Aug;9(4):551-62. Review.
•   Nguyen DH, Hildreth JE
  Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol. 2000 Apr;74(7):3264-72.
•   Nguyen DH, Taub DD
  Inhibition of chemokine receptor function by membrane cholesterol oxidation. Exp Cell Res. 2003 Nov 15;291(1):36-45.
•   Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD
  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853-60.
•   Park SW, Royal W 3rd, Semba RD, Wiegand GW, Griffin DE
  Expression of adhesion molecules and CD28 on T lymphocytes during human immunodeficiency virus infection. Clin Diagn Lab Immunol. 1998 Jul;5(4):583-7.
•   Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute
  ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002 Aug 7;40(3):567-72.
•   Pearce-Pratt R, Phillips DM
  Studies of adhesion of lymphocytic cells: implications for sexual transmission of human immunodeficiency virus. Biol Reprod. 1993 Mar;48(3):431-45.
•   Penzak SR, Chuck SK, Stajich GV
  Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection. Pharmacotherapy. 2000 Sep;20(9):1066-71.
•   Raggatt LJ, Partridge NC
  HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection. Drugs. 2002;62(15):2185-91. Review.
•   Sáez-Cirión A, Nir S, Lorizate M, Agirre A, Cruz A, Pérez-Gil J, Nieva JL
  Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring. J Biol Chem. 2002 Jun 14;277(24):21776-85. Epub 2002 Apr 2.
•   Schrier RD, McCutchan JA, Wiley CA
  Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages. J Virol. 1993 Oct;67(10):5713-20.
•   Shimada K, Miyauchi K, Daida H
  Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench. Circulation. 2004 May 11;109(18):e213-4; author reply e213-4.
•   Sklar PA, Masur H, Grubb JR, Voell J, Witek J, Ono A, Freed EO, Maldarelli F
  Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy. AIDS. 2005 Jul 1;19(10):1109-11.
•   Tremblay MJ, Fortin JF, Cantin R
  The acquisition of host-encoded proteins by nascent HIV-1. Immunol Today. 1998 Aug;19(8):346-51. Review.
•   Tsunetsugu-Yokota Y, Yasuda S, Sugimoto A, Yagi T, Azuma M, Yagita H, Akagawa K, Takemori T
  Efficient virus transmission from dendritic cells to CD4+ T cells in response to antigen depends on close contact through adhesion molecules. Virology. 1997 Dec 22;239(2):259-68.
•   United Nations Programme on HIV/AIDS (UNAIDS); United Nations Development Programme (UNDP)
  International consultation on the criminalization of HIV transmission: 31 October-2 November 2007, Geneva, Switzerland. Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, United Nations Development Programme (UNDP), New York, 2007. Reprod Health Matters. 2009 Nov;17(34):180-6. doi: 10.1016/S0968-8080(09)34466-3.
•   van der Goot FG, Harder T
  Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol. 2001 Apr;13(2):89-97. Review.
•   Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H
  Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Transplantation. 1994 Jul 15;58(1):42-5.
•   Vaughan CJ, Delanty N
  Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke. 1999 Sep;30(9):1969-73. Review.
•   Viard M, Parolini I, Sargiacomo M, Fecchi K, Ramoni C, Ablan S, Ruscetti FW, Wang JM, Blumenthal R
  Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol. 2002 Nov;76(22):11584-95.
•   Vincent N, Genin C, Malvoisin E
  Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim Biophys Acta. 2002 Dec 23;1567(1-2):157-64.
•   Wallays G, Ceuppens JL
  Ligation of leukocyte function-associated (LFA) molecule-1 provides an accessory signal for T-cell activation with pokeweed mitogen. Scand J Immunol. 1994 Feb;39(2):137-43.
•   Wang JK, Kiyokawa E, Verdin E, Trono D
  The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):394-9.
•   Waters L, Stebbing J, Jones R, Mandalia S, Bower M, Stefanovic M, Nelson M, Gazzard B
  The effect of statins on HIV rebound and blips. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):637-8.
•   Yilmaz A, Reiss C, Tantawi O, Weng A, Stumpf C, Raaz D, Ludwig J, Berger T, Steinkasserer A, Daniel WG, Garlichs CD
  HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis. 2004 Jan;172(1):85-93.
•   Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS
  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002 Nov 7;420(6911):78-84.
•   Zheng YH, Plemenitas A, Fielding CJ, Peterlin BM
  Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8460-5. Epub 2003 Jun 24.

Antiretroviral Effect of Lovastatin on HIV-1-infected Individuals Without Highly Active Antiretroviral Therapy (HAART): A Phase-II Randomized Clinical Trial (RCT)

Details for clinical trial NCT00721305